July 16, 2026
1 min read

Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US

A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies, marking a potential first step to imposing restrictions.

Leave a Reply

Your email address will not be published.

Previous Story

St. Bernard Chamber of Commerce Celebrates Ribbon Cutting for Paris Road Nutrition

Next Story

STAT+: Spring forward forever? Another daylight saving debate arrives in Congress

Previous Story

St. Bernard Chamber of Commerce Celebrates Ribbon Cutting for Paris Road Nutrition

Next Story

STAT+: Spring forward forever? Another daylight saving debate arrives in Congress

Latest from Blog

Go toTop